Changes in Biomarkers Using Prostaglandin Inhibitors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Biomarker Change Linked to Breast Cancer
Interventions: DRUG: placebo/celecoxib 400 mg and cholecalciferol 400 IU/cholecalciferol 2,000 IU
Sponsor: Hartford Hospital
Collaborators: Susan G. Komen Breast Cancer Foundation